Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RRBP1 pseudogene 2 (RRBP1P2) is a genomic locus derived from the ribosome binding protein 1 (RRBP1) gene. It does not encode a functional protein and is classified as a pseudogene. Unlike the protein-coding RRBP1, which is an endoplasmic reticulum membrane protein involved in ribosome association, secretory pathway regulation, and is implicated in cancer progression, RRBP1P2 has no recognized biological function, clinical utility, or therapeutic relevance[1][5]. In summary, RRBP1P2 is not a therapeutic or functional protein target, and queries about RRBP1P2 as a receptor or drug target are incorrect. Only its parent, RRBP1, is an established protein with cellular roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RRBP1 pseudogene 2 (RRBP1P2).